Publications of Y. Genzel

Roedig, J., Rapp, E., Genzel, Y., & Reichl, U. (2011)Impact of different influenza cultivation conditions on HA N-glycosylationIn: BMC Proceedings, P113doi: 10.1186/1753-6561-5-S8-P113.

Vester, D., Rapp, E., Kluge, S., Genzel, Y., & Reichl, U. (2010)Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von ProduktionszelllinienIn: Chemie Ingenieur Technik, 1496doi: 10.1002/cite.201050197.

Öncül, A., Kalmbach, A., Genzel, Y., Reichl, U., & Thevenin, D. (2009)Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-BioreaktorenIn: Chemie-Ingenieur-Technik, 1241 doi: 10.1002/cite.200950096.

Sidorenko, Y., Dauner, M., Genzel, Y., & Reichl, U. (2006)Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture MediaIn: Metabolic Engineering VI: Program, 102.

Pelz, L., Rüdiger, D., Hein, M., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Engineered defective interfering particles of influenza A virus for antiviral treatmentPresented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Dogra, T., Pelz, L., Boehme, J. D., Baelkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 17^th Vaccine CongressGlasgow (Scotland), September 24, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Exercise on vaccine designPresented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise.Presented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process IntensificationPresented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y.ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Development - From Master Seed to ProductionPresented at: ESACT Course 2023Llafranc (Spain), October 1, 2023.

Genzel, Y., Zinnecker, T. M., Göbel, S., & Reichl, U.Intensified cell-based virus production: A process development challenge for multiple cell-virus combinationsPresented at: 16^th PEACe ConferenceSitges (Spain), September 24, 2023.

Genzel, Y., Zinnecker, T. M., Göbel, S., & Reichl, U.Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus YieldPresented at: International Society for Vaccines (ISV) Annual CongressLausanne (Switzerland), October 22, 2023.

Genzel, Y., Zinnecker, T. M., Göbel, S., & Reichl, U.Increase in supply through use of new technologies for high yield vaccinesPresented at: Flanders VaccineBrussels (Belgium), November 12, 2023.

Göbel, S., Dallmeier, K., Jordan, I., de Jong, J. D., Reichl, U., & Genzel, Y.Intensified production for a yellow fever - ZIKA virus vaccine candicatePresented at: Democratization of biotherapies: new manufacturing modalities and intensification'sOxford, UK, June 21, 2023.

Göbel, S., Jaén, K. E., Pelz, L., Reiter , M., Altomonte, J., Reichl, U., & Genzel, Y.Intensifiying OSB processes for high titer virus productionPresented at: 5^th large scale meeting: Orbital shaken bioreactorsGirona (Spain), June 5, 2023.

Küchler, J., Opitz, P., Rüdiger, D., Kupke, S. Y., Genzel, Y., Benndorf, D., & Reichl, U.Absolute quantification of influenza A virus proteins during single-round replication in different host cellsPresented at: 6^th Workshop on Virus DynamicsNagoya (Japan), July 4, 2023.

Pelz, L., Dogra, T., Boehme, J. D., Hein, M. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivoPresented at: Cell Culture Engineering (CCE) XVIII Cancun (Mexico), April 23, 2023.

Pelz, L., Genzel, Y., Kupke, S. Y., & Reichl, U.In-depth characterization and cell culture-based production of influenza A virus defective interfering particlesPresented at: ACTIP fellowship sessionDublin (Ireland), October 11, 2023.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. D., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral TherapyPresented at: Vir-AI-DIP WorkshopHamburg (Germany), July 18, 2023.

Zinnecker, T. M., Badri, N., Araujo, D., Hinkelmann, A., Thiele, K., Reichl, U., & Genzel, Y.Novel approach towards vaccine manufacturing: from single-cell cloning to high-yielding influenza virus productionPresented at: 4^th Global Bioprocessing, Bioanalytics and ATMP Manufacturing CongressDublin (Ireland), May 15, 2023.